Eli Lilly and Company has announced plans to invest more than $1.2 billion to expand and modernize its Lilly del Caribe manufacturing site in Puerto Rico.

Agreement expands Piramal’s payload-linker platform and bioconjugate abilities.

Ajinomoto Co., Inc. has signed a licensing agreement with Astellas Pharma Inc. for the use of AJICAP—an antibody-drug conjugate (ADC) development and manufacturing technology—as part of its CDMO ...

Thermo Fisher Scientific Inc. has agreed to acquire Clario Holdings Inc., a provider of digital endpoint data solutions for clinical trials, in a cash transaction valued at $8.875 billion.

Debiopharm has entered a strategic research collaboration with NetTargets to design and advance the discovery of novel, synergistic drug combinations for Debiopharm’s next-gen ADCs.

The Pistoia Alliance, a global, not-for-profit alliance, is launching Phase 3 of its Chemistry, Manufacturing and Controls (CMC) Process Ontology project.

Wheeler Bio has partnered with Mitsubishi Corporation to expand its commercial reach and business development activities across the Asia-Pacific region.

Will transfer commercial manufacturing for a leading injectable pharmaceutical product from the current manufacturer to Lifecore’s facilities.

Ajinomoto Bio-Pharma Services and Olon S.p.A. have entered into a strategic partnership to deliver drug substance manufacturing services.

Senior Director of Business Development shares insight on industry trends and outsourcing.

Apeloa Pharmaceutical, a global provider of technology-driven pharmaceutical manufacturing solutions, has passed its 20th U.S. FDA inspection.

Cryoport Systems was actively involved in the development of the ISO 21973 standard through its participation in the Standards Coordinating Body working group. The standard, intro ...